Cargando…
Current Experimental Studies of Gene Therapy in Parkinson's Disease
Parkinson's disease (PD) was characterized by late-onset, progressive dopamine neuron loss and movement disorders. The progresses of PD affected the neural function and integrity. To date, most researches had largely addressed the dopamine replacement therapies, but the appearance of L-dopa-ind...
Autores principales: | Lin, Jing-ya, Xie, Cheng-long, Zhang, Su-fang, Yuan, Weien, Liu, Zhen-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413509/ https://www.ncbi.nlm.nih.gov/pubmed/28515689 http://dx.doi.org/10.3389/fnagi.2017.00126 |
Ejemplares similares
-
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease
por: Chen, Wei, et al.
Publicado: (2016) -
Identification of necroptosis-related genes in Parkinson’s disease by integrated bioinformatics analysis and experimental validation
por: Lei, Cheng, et al.
Publicado: (2023) -
Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease
por: Wan, Ying, et al.
Publicado: (2017) -
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
por: Ma, Kai, et al.
Publicado: (2018) -
Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)